| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11325-007-0143-9 |
| P698 | PubMed publication ID | 17906885 |
| P2093 | author name string | Thomas Münzer | |
| Jonathan Myers | |||
| Hans Rickli | |||
| Peter Ammann | |||
| Micha T Maeder | |||
| Wolfgang Korte | |||
| Otto D Schoch | |||
| Christoph Hürny | |||
| P2860 | cites work | A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale | Q28256570 |
| A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group | Q29614889 | ||
| Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force | Q29615535 | ||
| Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study | Q29615583 | ||
| Prospective study of the association between sleep-disordered breathing and hypertension | Q29620492 | ||
| Impact of obesity on plasma natriuretic peptide levels | Q34295497 | ||
| Physiological cardiac reserve: development of a non-invasive method and first estimates in man. | Q34469508 | ||
| How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study | Q34518561 | ||
| ATS/ACCP Statement on cardiopulmonary exercise testing | Q35043791 | ||
| Oxygen uptake kinetics during low level exercise in patients with heart failure: relation to neurohormones, peak oxygen consumption, and clinical findings | Q35370589 | ||
| Essential biochemistry and physiology of (NT-pro)BNP. | Q35677297 | ||
| Sympathetic neural mechanisms in obstructive sleep apnea. | Q35764596 | ||
| Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea | Q36840423 | ||
| Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms | Q38776803 | ||
| Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. | Q39230151 | ||
| Determination of aerobic capacity and the severity of chronic cardiac and circulatory failure | Q39678198 | ||
| N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults | Q40432735 | ||
| Usefulness of B-type natriuretic peptide and C-reactive protein in predicting the presence or absence of left ventricular hypertrophy in patients with systemic hypertension | Q43506651 | ||
| Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea | Q44387214 | ||
| Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay | Q44668764 | ||
| B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure | Q44878893 | ||
| Technical considerations related to the minute ventilation/carbon dioxide output slope in patients with heart failure | Q44895256 | ||
| B-type natriuretic peptide levels in obese patients with advanced heart failure | Q46213636 | ||
| Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings | Q46250748 | ||
| Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. | Q46595107 | ||
| N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. | Q46676025 | ||
| Cardiopulmonary exercise testing in obstructive sleep apnea syndrome | Q47646519 | ||
| Impact of obstructive sleep apnoea on left ventricular mass and global function | Q47754397 | ||
| Cardiopulmonary responses to exercise in moderate-to-severe obstructive sleep apnea. | Q47833255 | ||
| Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit. | Q48174219 | ||
| N-terminal pro-brain natriuretic peptide for detection of cardiovascular stress in patients with obstructive sleep apnea syndrome | Q48363292 | ||
| The nocturnal secretion of cardiac natriuretic peptides during obstructive sleep apnoea and its response to therapy with nasal continuous positive airway pressure | Q48368787 | ||
| Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man | Q48370412 | ||
| Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea | Q48466428 | ||
| Does obstructive sleep apnea affect aerobic fitness? | Q48486406 | ||
| Obstructive sleep apnea and plasma natriuretic peptide levels in a community-based sample | Q48486750 | ||
| Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study | Q48491751 | ||
| brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure | Q48496304 | ||
| NT-pro-BNP in obstructive sleep apnea syndrome is decreased by nasal continuous positive airway pressure | Q48505840 | ||
| Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure | Q48506489 | ||
| Plasma brain natriuretic peptide in obstructive sleep apnea | Q48583498 | ||
| Endothelial Function in Obstructive Sleep Apnea and Response to Treatment | Q48616765 | ||
| Left ventricular hypertrophy is a common echocardiographic abnormality in severe obstructive sleep apnea and reverses with nasal continuous positive airway pressure | Q48621613 | ||
| Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction | Q48670679 | ||
| Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study | Q48704784 | ||
| Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study | Q48745221 | ||
| Regional fat distribution by dual-energy X-ray absorptiometry: comparison with anthropometry and application in a clinical trial of growth hormone and exercise. | Q54192005 | ||
| Simplified calculation of body-surface area. | Q55060911 | ||
| Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio | Q57217547 | ||
| Transesophageal Echocardiography | Q58072085 | ||
| Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction | Q74536617 | ||
| Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association | Q74582158 | ||
| BNP and N-terminal proBNP are both extracted in the normal kidney | Q82220033 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 7-16 | |
| P577 | publication date | 2008-03-01 | |
| P1433 | published in | Sleep and Breathing | Q15762247 |
| P1476 | title | N-terminal pro-B-type natriuretic peptide and functional capacity in patients with obstructive sleep apnea | |
| P478 | volume | 12 |
| Q26751303 | A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease |
| Q38664211 | Biomarkers in Sleep Apnea and Heart Failure |
| Q37176465 | Cardiorespiratory fitness and sleep-related breathing disorders |
| Q37222763 | How does serum brain natriuretic peptide level change under nasal continuous positive airway pressure in obstructive sleep apnea-hypopnea syndrome? |
| Q43265261 | Impact of CPAP treatment on cardiac biomarkers and pro-BNP in obstructive sleep apnea syndrome |
| Q48455651 | N-terminal pro-B-type naturetic peptide (NTBNP): so much promise and such a disappointment |
| Q38561217 | Plasma natriuretic peptides in children and adolescents with obstructive sleep apnea and their changes following intervention. |
| Q85168904 | Serial NT-proBNP measurements for risk stratification of patients with decompensated heart failure |
| Q38754350 | Sleep apnea in total joint arthroplasty patients and the role for cardiac biomarkers for risk stratification: an exploration of feasibility. |
Search more.